Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 938, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2022.175411
Keywords
Guggulsterone; Autophagy; Migration; Invasion; Protein degradation; Glioblastoma
Categories
Ask authors/readers for more resources
This study found that guggulsterone (GS) can inhibit the migration and invasion abilities of glioblastoma multiforme (GBM) cells, and the underlying mechanism may involve degradation by proteasomes and lysosomes.
Glioblastoma multiforme (GBM) is a deadly brain malignancy, and current therapies offer limited survival benefit. The phytosterol guggulsterone (GS) has been shown to exhibit antitumor efficacy. This study aimed to investigate the effects of GS on migration and invasion and its underlying mechanisms in human GBM cell lines. After GS treatment, the survival rate of GBM cells was reduced, and the migration and invasion abilities of GBM cells were significantly decreased. There was also concomitant decreased expression of focal adhesion complex, matrix metalloproteinase-2 (MMP2), MMP9 and cathepsin B. Furthermore, GS induced ERK phosphorylation and autophagy, with increased p62 and LC3B-II expression. Notably, treatment of in GBM cells with the proteasome inhibitor MG132 or the lysosome inhibitor NH4Cl reversed the GS-mediated inhibition of migration and invasion. In an orthotopic xenograft mouse model, immunohistochemical staining of brain tumor tissues demonstrated that MMP2 and cathepsin B expression was reduced in GS-treated mice. GS treatment inhibited GBM cell migration and invasion via proteasomal and lysosomal degradation, suggesting its therapeutic potential in clinical use in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available